One Year Follow-Up Results From Preserve-Ami: A Randomized, Double-Blind, Placebo Controlled Clinical Trial Of Intracoronary Infusion Of Autologous Cd34+Cells In Patients With Left Ventricular Dysfunction Post Stem

Arshed Quyyumi,Dean Kereiakes,David Shavelle,Timothy Henry, Ali Denktas,Ahmed Abdel-Latif,Catalin Toma, Gregory Barsness,Stephen Frohwein,Richard Schatz,Martin Cohen,Charles Davidson,Nabil Dib,Marc Klapholz,Gary Schaer,Alejandro Vasquez,Andrew Pecora,Thomas Moss, Pamela Hyde, Anna Maria Kanakaraj, Le Dich,Vitaly Druker, Candice Junge, Robed Preti,Douglas Losordo

Journal of the American College of Cardiology（2015）

引用 6|浏览36

暂无评分

摘要

ST segment Elevation Myocardial Infarction (STEMI) affects 160,000 annually in the US. Guidelines direct immediate revascularization and adjunctive medical therapies. Yet STEMI victims remain at risk for infarct expansion, heart failure, reinfarction, repeat revascularization and death. In pre-

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要